Kenvue Drops on Report RFK Jr. Will Link Tylenol to Autism (5)

Sept. 5, 2025, 8:05 PM UTC

Kenvue Inc.’s shares fell after the Wall Street Journal reported that Health and Human Services Secretary Robert F. Kennedy Jr. is likely to link the company’s Tylenol painkiller to autism, though the agency said the news report was “speculation.”

The federal government is expected to release its findings on autism this month. The Journal, citing people familiar with the matter, reported Friday that it’s likely to say that use of over-the-counter pain medication with acetaminophen, which is the active ingredient in Tylenol, may cause autism.

But HHS pushed back on this. “We are using gold-standard science to get to ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.